60
Participants
Start Date
July 31, 2002
Primary Completion Date
June 30, 2005
Study Completion Date
June 30, 2005
Quetiapine
Columbia University, Alzheimer's Disease Research Center, New York
Maimonides Medical Center, Brooklyn
Parkinson's Disease and Movement Disorders Center, Albany Medical College, Albany
Syracuse VA Medical Center, Syracuse
University of Rochester Medical Center, Alzheimer's Disease Center, Rochester
Emory University, Alzheimer's Disease Center, Atlanta
Medical College of Georgia, Augusta
Rush University Medical Center, Chicago
Southern Illinois University, School of Medicine, Springfield
University of Nevada, Las Vegas
VA Healthcare System Long Beach, Long Beach
University of California, San Diego, Alzheimer's Disease Center, La Jolla
Stanford/VA Aging Clinical Research Center, Department of Psychiatry & Behavioral Sciences, Palo Alto
University of Alabama at Birmingham, Alzheimer's Disease Research Center, Birmingham
University of California at Los Angeles, Alzheimer's Disease Center, Los Angeles
E. N. Rogers Memorial Veterans Hospital, Bedford
University of Pittsburgh, Alzheimer's Disease Research Center, Pittsburgh
University of Texas Southwestern Medical Center at Dallas, Alzheimer's Disease Center, Dallas
Memory Clinic at Southwestern Vermont Medical Center, Bennington
Fletcher Allan Health Care, Inc., Burlington
University of Washington at Seattle, Alzheimer's Disease Research Center, Seattle
National Institute on Aging (NIA)
NIH